Search

everythinglearnresearchcommunity

for

Search:↓

Both scalp cooling and chemical cooling caps effectively prevent hair loss in breast cancer patients undergoing chemotherapy.

Genetic differences affect breast cancer treatment success with tamoxifen in South African patients.

Nanotechnology improves CRISPR-Cas9 delivery for cancer treatment, but challenges remain.

Chemotherapy for breast cancer often causes significant and lasting hair loss.

Combining hyperthermia with natural compounds and conventional treatments improves cancer therapy effectiveness and reduces side effects.

Extracellular vesicles show promise for medical use but face challenges in standardization and safety.

SCUBE3 is a potential target for cancer and alopecia treatment but is challenging to target due to its varied roles.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.

Abraham's family infertility may have a genetic explanation.

Herbal remedies may help with hair loss but need more research.

Natural killer and CD8+ T cells play a key role in hair loss in androgenetic alopecia.

Chemotherapy worsens nutritional status in breast cancer patients, requiring targeted nutritional strategies.

Nanoformulations improve luteolin's effectiveness as a cancer treatment.

Nanomaterials can significantly improve wound healing and future treatments may include smart, real-time monitoring.

Metformin might help treat certain skin conditions, but more research is needed.

Early detection and a multidisciplinary approach are crucial for improving gastric cancer survival rates.

The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.

Lotion with fucoidan from brown seaweed improved skin and reduced allergy symptoms in mice with dermatitis.

Manipulating EGFR signaling may help treat hair loss and promote hair growth.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Betacellulin helps blood vessel growth in wounds but delays hair growth.

HNG helps hair grow by keeping hair in the growth phase longer.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

BMI is a simple, cost-effective tool for screening obesity and related diseases.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Brassinosteroids may be useful in treating cancer, infections, and other diseases.

Nanocarriers can improve skin drug delivery but face challenges in clinical use.

GLI1 might protect against the start of skin cancer and is not linked to cancer severity.